From: Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
HH+HR
RR
Total
Null (%)
10.1
26.3
13.3
Moderate (%)
27.8
10.5
24.5
Good (%)
62.0
63.2
62.2